## Abstract ## Purpose To develop a method for automatically triggering centric data acquisition during contrast‐enhanced whole‐heart coronary magnetic resonance angiography (MRA). ## Materials and Methods The hypothesis of this work is that the blood signal changes during contrast infusion can
Volume-targeted and whole-heart coronary magnetic resonance angiography using an intravascular contrast agent
✍ Scribed by Lijun Tang; Nico Merkle; Michael Schär; Grigorios Korosoglou; Meiyappan Solaiyappan; Vinzenz Hombach; Matthias Stuber
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 220 KB
- Volume
- 30
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Purpose
To compare volume‐targeted and whole‐heart coronary magnetic resonance angiography (MRA) after the administration of an intravascular contrast agent.
Materials and Methods
Six healthy adult subjects underwent a navigator‐gated and ‐corrected (NAV) free breathing volume‐targeted cardiac‐triggered inversion recovery (IR) 3D steady‐state free precession (SSFP) coronary MRA sequence (t‐CMRA) (spatial resolution = 1 × 1 × 3 mm^3^) and high spatial resolution IR 3D SSFP whole‐heart coronary MRA (WH‐CMRA) (spatial resolution = 1 × 1 × 2 mm^3^) after the administration of an intravascular contrast agent B‐22956. Subjective and objective image quality parameters including maximal visible vessel length, vessel sharpness, and visibility of coronary side branches were evaluated for both t‐CMRA and WH‐CMRA.
Results
No significant differences (P = NS) in image quality were observed between contrast‐enhanced t‐CMRA and WH‐CMRA. However, using an intravascular contrast agent, significantly longer vessel segments were measured on WH‐CMRA vs. t‐CMRA (right coronary artery [RCA] 13.5 ± 0.7 cm vs. 12.5 ± 0.2 cm; P < 0.05; and left circumflex coronary artery [LCX] 11.9 ± 2.2 cm vs. 6.9 ± 2.4 cm; P < 0.05). Significantly more side branches (13.3 ± 1.2 vs. 8.7 ± 1.2; P < 0.05) were visible for the left anterior descending coronary artery (LAD) on WH‐CMRA vs. t‐CMRA. Scanning time and navigator efficiency were similar for both techniques (t‐CMRA: 6.05 min; 49% vs. WH‐CMRA: 5.51 min; 54%, both P = NS).
Conclusion
Both WH‐CMRA and t‐CMRA using SSFP are useful techniques for coronary MRA after the injection of an intravascular blood‐pool agent. However, the vessel conspicuity for high spatial resolution WH‐CMRA is not inferior to t‐CMRA, while visible vessel length and the number of visible smaller‐diameter vessels and side‐branches are improved. J. Magn. Reson. Imaging 2009;30:1191–1196. © 2009 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Purpose: To evaluate gadocoletic acid (b-22956), a gadolinium-based paramagnetic blood pool agent, for contrast-enhanced coronary magnetic resonance angiography (mra) in a phase i clinical trial, and to compare the findings with those obtained using a standard noncontrast t2 preparation sequence
The ability of a blood pool contrast agent to enhance MR coronary angiography was defined. The proximal coronary vessels of pigs were imaged before and after administration of Gd-DTPA bound covalently to bovine serum albumin (0.2 mmol/ kg). The contrast agent resulted in a reduction of the blood T 1
## Abstract ## Purpose To evaluate the combined use of carbon dioxide (CO~2~) and a gadolinium‐based blood‐pool agent for magnetic resonance angiography (MRA). ## Materials and Methods After an initial intravenous injection of the blood‐pool agent Gadomer (Schering AG, Germany), repeated transca
## Abstract ## Purpose To evaluate the feasibility of improving 3.0T steady‐state free precession (SSFP) whole‐heart coronary magnetic resonance angiography (MRA) using short‐TR (repetition time) VIPR (vastly undersampled isotropic projection reconstruction). ## Materials and Methods SSFP is hig
Functional magnetic resonance imaging (fMRI) has been applied to study rat focal brain activation induced by intravenous administration of the GABA(A) antagonist bicuculline. Using magnetite nanoparticles as a blood pool contrast agent, local changes in cerebral blood volume (CBV) were assessed with